"Randomized phase II trial and tumor mutational spectrum analysis from " by Bruno Bastos

Menu

Skip to main content

All Publications

Bruno Bastos, Miami Cancer InstituteFollow

Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201)

Publication Date

2020

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Clinical Cancer Research (2020) 26(4):804-811

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS